Rankings
▼
Calendar
MNKD Q4 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$58M
+62.2% YoY
Gross Profit
$40M
69.1% margin
Operating Income
$8M
13.4% margin
Net Income
$1M
2.4% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
+14.1%
Cash Flow
Operating Cash Flow
$22M
Free Cash Flow
$16M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$475M
Total Liabilities
$721M
Stockholders' Equity
-$246M
Cash & Equivalents
$238M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$58M
$36M
+62.2%
Gross Profit
$40M
$20M
+102.7%
Operating Income
$8M
-$13M
+161.4%
Net Income
$1M
-$18M
+107.8%
Revenue Segments
License and Service
$23M
100%
← FY 2023
All Quarters
Q1 2024 →